Lovastatin in Treating Patients At High Risk of Melanoma

Summary

The use of lovastatin may slow disease progression in patients at high risk of melanoma. It is not yet known whether lovastatin is more effective than a placebo in treating patients at high risk of melanoma. This randomized phase II trial studies how well giving lovastatin or placebo works in treating patients at high risk of melanoma.

Timeline

Start

2007-05

Primary completion

2011-04

Completion

2012-02

Drugs

Indications